Fact CheckerSign in

NCT06363526Enrolling by invitation

Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.

Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.

Source: ClinicalTrials.gov · Last updated 1 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
12 (estimated)
First submitted
22 Mar 2024
Start date
5 Feb 2025
Primary completion date
30 Jul 2025
Lead sponsor
University of Malaga
NCT number
NCT06363526

What you commit to

  • Study type: Interventional
  • Planned participants: 12
  • From 5 Feb 2025 to the primary completion date, 30 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who present associated heart disease.
  • Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded.

Other

  • Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.

Who the study is looking for

  • Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen.
  • Aged between 5 and 20 years.
  • Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20.

Age in the registry: 5 years to 20 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rocío Martín-Valero
Coordinator of this site? Confirm its status
MálagaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.